Beta-Transducin Repeats-Containing Proteins as an Anticancer Target

por Kim, Dong Joon, Yi, Yong Weon, Seong, Yeon-Sun
Publicado 2023

Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells

por You, Kyu Sic, Yi, Yong Weon, Cho, Jeonghee, Seong, Yeon-Sun
Publicado 2021

Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS Cells

por Lee, Sue Nyoung, Hong, Kyeong-Man, Seong, Yeon Sun, Kwak, Sahng-June
Publicado 2020

BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells

por DUONG, HONG-QUAN, HWANG, JAE SEOK, KIM, HEE JEONG, SEONG, YEON-SUN, BAE, INSOO
Publicado 2012

Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells

por Duong, Hong-Quan, You, Kyu Sic, Oh, Seunghoon, Kwak, Sahng-June, Seong, Yeon-Sun
Publicado 2017

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer

por You, Kyu Sic, Yi, Yong Weon, Cho, Jeonghee, Park, Jeong-Soo, Seong, Yeon-Sun
Publicado 2021

Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

por Yi, Yong Weon, You, Kyu Sic, Park, Jeong-Soo, Lee, Seok-Geun, Seong, Yeon-Sun
Publicado 2021

β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells

por Yi, Yong Weon, Kang, Hyo Jin, Bae, Edward Jeong, Oh, Seunghoon, Seong, Yeon-Sun, Bae, Insoo
Publicado 2015

Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6

por YI, YONG WEON, YOU, KYUSIC, BAE, EDWARD JEONG, KWAK, SAHNG-JUNE, SEONG, YEON-SUN, BAE, INSOO
Publicado 2015

Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells

por DUONG, HONG-QUAN, HWANG, JAE SEOK, KIM, HEE JEONG, KANG, HYO JIN, SEONG, YEON-SUN, BAE, INSOO
Publicado 2012

Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells

por Yi, Yong Weon, You, Kyu Sic, Han, Sanghee, Ha, In Jin, Park, Jeong-Soo, Lee, Seok-Geun, Seong, Yeon-Sun
Publicado 2022

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells

por Yi, Yong Weon, Hong, Wooyoung, Kang, Hyo Jin, Kim, Hee Jeong, Zhao, Wenjing, Wang, Antai, Seong, Yeon-Sun, Bae, Insoo
Publicado 2013

Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells

por DUONG, HONG-QUAN, YI, YONG WEON, KANG, HYO JIN, BAE, INSOO, JANG, YOUNG-JOO, KWAK, SAHNG-JUNE, SEONG, YEON-SUN
Publicado 2014

HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction

por Kang, Hyo Jin, Yi, Yong Weon, Hong, Young Bin, Kim, Hee Jeong, Jang, Young-Joo, Seong, Yeon-Sun, Bae, Insoo
Publicado 2014

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine

por DUONG, HONG-QUAN, YI, YONG WEON, KANG, HYO JIN, HONG, YOUNG BIN, TANG, WENXI, WANG, ANTAI, SEONG, YEON-SUN, BAE, INSOO
Publicado 2013

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine

por Duong, Hong-Quan, Hong, Young Bin, Kim, Jung Soon, Lee, Hee-Seok, Yi, Yong Weon, Kim, Yeon Jeong, Wang, Antai, Zhao, Wenjing, Cho, Chi Heum, Seong, Yeon-Sun, Bae, Insoo
Publicado 2013